tiprankstipranks
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market
Holding TSE:KNE?
Track your performance easily

Kane Biotech (KNE) Financial Statements

1 Followers

Kane Biotech Financial Overview

Kane Biotech's market cap is currently ―. The company's EPS TTM is C$-0.034; its P/E ratio is ―; Kane Biotech is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.28M$ 620.44K$ 51.89K$ -1.90M$ 717.85K
Gross Profit$ 558.75K$ 360.50K$ 40.05K$ -881.35K$ 315.26K
EBIT$ -613.86K$ -1.12M$ -1.18M$ -637.84K$ -1.17M
EBITDA$ -567.46K$ -1.06M$ -1.12M$ -589.54K$ -1.10M
Net Income Common Stockholders$ -605.81K$ 9.18M$ -1.40M$ -1.58M$ -1.38M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 544.38K$ 1.01M$ 826.70K$ 749.25K$ 1.62M
Total Assets$ 3.91M$ 4.07M$ 5.80M$ 5.68M$ 6.01M
Total Debt$ 1.23M$ 928.88K$ 7.84M$ 9.25M$ 9.16M
Net Debt$ 689.15K$ -81.05K$ 7.01M$ 8.50M$ 7.54M
Total Liabilities$ 4.59M$ 4.80M$ 15.33M$ 14.09M$ 13.02M
Stockholders Equity$ -688.65K$ -721.70K$ -11.73M$ -10.56M$ -9.19M
Cash Flow-
Free Cash Flow$ -546.58K$ -2.20M$ -991.36K$ -735.69K$ -748.06K
Operating Cash Flow$ -538.13K$ -2.17M$ -984.19K$ -789.89K$ -715.27K
Investing Cash Flow$ -8.46K$ 9.04M$ -10.32K$ -12.20K$ -32.79K
Financing Cash Flow$ 81.03K$ -7.57M$ 809.62K$ 597.84K$ 1.23M
Currency in USD

Kane Biotech Earnings and Revenue History

Kane Biotech Debt to Assets

Kane Biotech Cash Flow

Kane Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis